Symptomatic cytomegalovirus infection in seropositive kidney recipients: reinfection with donor virus rather than reactivation of recipient virus.
about
Human CMV-specific T-cell responses in kidney transplantation; toward changing current risk-stratification paradigmThe dynamics of human cytomegalovirus replication in vivoCurrent status of renal transplantation.Strain-specific neutralization of human cytomegalovirus isolates by human sera.New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipientsB cell repertoire analysis identifies new antigenic domains on glycoprotein B of human cytomegalovirus which are target of neutralizing antibodies.Natural killer cell dependent within-host competition arises during multiple MCMV infection: consequences for viral transmission and evolution.Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trialRisk of cytomegalovirus transmission by blood products to immunocompromised patients and means for reduction.Strain-specific neutralizing antibody responses against human cytomegalovirus envelope glycoprotein N.Cytomegalovirus disease in African-American kidney transplant patientsCytomegalovirus DNA detection in sera from patients with active cytomegalovirus infections.Restriction endonuclease analysis of human and bovine group B streptococci for epidemiologic study.Impaired direct priming of CD8 T cells by donor-derived cytomegalovirus following kidney transplantation.Molecular biology of cytomegalovirusDesirability and feasibility of a vaccine against cytomegalovirus.The pathogenesis of human cytomegalovirus.Human cytomegalovirus infection.Concurrent genotyping and quantitation of cytomegalovirus gB genotypes in solid-organ-transplant recipients by use of a real-time PCR assayCytomegalovirus and other herpesviruses infections in heart and bone marrow transplant recipients.Functional impairment of cytomegalovirus specific CD8 T cells predicts high-level replication after renal transplantation.Early detection of active cytomegalovirus (CMV) infection after heart and kidney transplantation by testing for immediate early antigenemia and influence of cellular immunity on the occurrence of CMV infection.Risk factors, survival, and impact of prophylaxis length in cytomegalovirus-seropositive lung transplant recipients: A prospective, observational, multicenter study.Transfusion-transmitted cytomegalovirus infection.Transfusion-transmitted cytomegalovirus: the part-time pathogen.Detection of human cytomegalovirus antigenaemia: a rapid diagnostic technique for predicting cytomegalovirus infection/pneumonitis in lung and heart transplant recipients.Risk factors for cytomegalovirus reactivation after liver transplantation: can pre-transplant cytomegalovirus antibody titers predict outcome?Transient residence of a seropositive organ is sufficient to transfer human cytomegalovirus to a seronegative recipient.Porcine cytomegalovirus in pigs being bred for xenograft organs: progress towards control.Differences between the quantitative antigenemia assay and the cobas amplicor monitor quantitative PCR assay for detecting CMV viraemia in bone marrow and solid organ transplant patients.Pretransplant immediately early-1-specific T cell responses provide protection for CMV infection after kidney transplantation.The association of cytomegalovirus sero-pairing with outcomes and costs following cadaveric renal transplantation prior to the introduction of oral ganciclovir CMV prophylaxis.Evaluation by immune scanning electron microscopy of foscarnet treatment of cytomegalovirus infection in patients with renal transplants.Cytomegalovirus (CMV) prophylaxis by acyclovir in pre-transplant CMV-positive renal transplant recipients.Factors associated with the development of cytomegalovirus infection following solid organ transplantation.Isolated heart and liver transplant recipients are at low risk for polyomavirus BKV nephropathy.
P2860
Q26850340-9908F1C3-4504-4ACC-8328-58769290AE14Q28141142-16F7C93E-ED61-439D-867B-191E6427520FQ33558294-D8CBFCE9-C1CE-4D6A-A37E-F3B332117957Q33640031-2803054B-5239-4646-A875-43D482C6DE09Q33812425-1CCF7ABD-215B-4459-A920-FF812404E832Q33996614-CB2E93EC-DC1C-41E5-883B-31DD2A507E16Q34539825-A58681C9-A584-48A0-943C-7BD68B7233C5Q34786700-D3F7FB98-815B-42F6-860A-EFCB71B225A8Q35732096-B441AB26-2D1E-4A23-A2F0-9F3F521570E9Q36017790-6E92C65D-A3AE-45F7-9F1B-F929374E5875Q36614140-F138226A-BD9C-43E2-9F98-C1D30B559AE0Q37124499-440A2ADE-08C3-49B7-8444-7C5D3A9A29ADQ37175206-028DD100-7BE4-45FE-AAAA-6AB7F15100D3Q37202784-B3B6C6D6-11F5-4648-8A5F-7E36B05D0C1FQ37903241-D29EE3CF-622E-40F0-A598-E188C6A1D89BQ38100041-06E80022-A41B-4576-BF73-63C97772EF85Q38247785-CCD36B3C-EC55-4C5E-BF57-B35D7E2BCF95Q38284547-6EFAA157-4138-4BB0-A072-0FE664BAB737Q38359566-74BCED5D-1AE7-45E2-BA78-3FB533CC5E38Q39584883-F0AEC2CF-658F-4029-9580-EA3EDDC85395Q40115981-C584FDCD-6ADE-4590-AADD-F982C620FEC6Q40202544-C30300AB-E326-422B-A828-358D3467C37CQ40293836-E1453116-9392-4516-9A51-4950A901F144Q40505203-9AEE81DA-BA45-4E36-920C-19702FD11E19Q40968081-6BE31CE0-22C2-47D5-A4F1-5C2F6224299DQ41220260-9E20DEE7-81EF-4172-9054-E98221844FC6Q41537054-D7020C2A-A92F-48CF-8BCA-1A38EE5B646EQ42229229-51511687-0E11-4E32-8468-7DA032F9F4ACQ43216472-0993CE7A-D471-4405-9807-EFD88B29DAD8Q43652322-141228EB-ADF2-4655-9212-36C3F54259F1Q43653857-A37B81A9-C7E1-457D-ADE5-88236B21AB85Q44402541-DD7D74CE-0CB8-4669-BA39-AD337AB94F7CQ44662429-0A831845-B545-4399-94CA-BBC8492069B7Q45259016-301946E8-9DE1-484C-A27F-CAD05AA95140Q54388614-577AF8FF-65AA-4717-B566-588EC62FEBD9Q54593448-8C4FA29C-8812-4620-91C5-DED723A62907
P2860
Symptomatic cytomegalovirus infection in seropositive kidney recipients: reinfection with donor virus rather than reactivation of recipient virus.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Symptomatic cytomegalovirus in ...... activation of recipient virus.
@en
type
label
Symptomatic cytomegalovirus in ...... activation of recipient virus.
@en
prefLabel
Symptomatic cytomegalovirus in ...... activation of recipient virus.
@en
P2093
P1433
P1476
Symptomatic cytomegalovirus in ...... activation of recipient virus.
@en
P2093
J E Grundy
J Moorhead
O N Fernando
P D Griffiths
P304
P356
10.1016/S0140-6736(88)90685-X
P407
P577
1988-07-01T00:00:00Z